Although fresh frozen plasma (FFP) transfusions are common practice in neonatology,
robust evidence on their use is lacking. The aim of this study was to systematically review …

Objective To estimate the incidence of blood product transfusion, including red blood cells,
platelets, and plasma, and characterize pretransfusion hematologic values for infants during …

Background Approximately 1% to 2% of all hospitalized children receive a transfusion of
blood products, in Germany as in other countries. High-quality scientific evidence on …

Background While previous studies have described the use of blood components in subsets
of children, such as the critically ill, little is known about transfusion practices in hospitalized …

Critically ill children commonly receive coagulant products (plasma and/or platelet
transfusions) to prevent or treat hemorrhage or correct coagulopathy. Unique aspects of …

Background There are limited standards guiding the selection and processing of blood
components specific for neonatal and pediatric transfusions. Therefore, blood banks (BBs) …

Objective To evaluate whether transfusions in infants born preterm contribute to the
pathogenesis of bronchopulmonary dysplasia (BPD). Study design We conducted a …

Background To evaluate transfusion practices in pediatric oncology and hematopoietic stem
cell transplant (HSCT) patients. Study design and methods This is a multicenter …

Background Red blood cells (RBCs) are an essential factor to consider for modern
medicine, but planning the future collection of RBCs and supply efforts for coping with …

Abstract Background The Recipient Epidemiology and Donor Evaluation Study‐IV‐Pediatric
(REDS‐IV‐P) is the fourth iteration of the National Heart, Lung, and Blood Institute's REDS …